ALL Forensic analysis
BUYConviction: 8/10Price: $224.5810-Q
Loading technical data…
Price Targets (12m)
Bull Case
$265.00
+18.0% from current
Base Case
$240.00
+6.9% from current
Bear Case
$205.00
-8.7% from current
Detailed research
PART 1: TRADING EXECUTION
Trading Setup & Entry Strategy
- >Entry Zone: Initiate 30% position at $219.00 - $220.00 (retest of 5-day SMA). Add 40% at $212.00 (confluence of 50-day SMA). Hold 30% for breakout confirmation above $226.00.
- >Stop Loss: $205.50 (hard stop below 200-day SMA support at $206.67).
- >Take Profit: $238.00 (initial target) and $250.00 (extension target).
- >Risk/Reward: ~1:2.4 R/R ratio.
- >Max Hold: 2 weeks.
PART 2: DETAILED RESEARCH
Recent Material Events (8-K Analysis)
Recent filings center on routine corporate governance and financial disclosures. The Q1 2026 10-Q (filed April 29) shows a massive $2.43B quarterly net income, signaling a high-conviction turnaround in core underwriting performance.
Financial Health & Forensic Flags
- >Revenue Quality: Strong. Underwriting income for Allstate Protection segment jumped from $364M (Q1 2025) to $2.66B (Q1 2026).
- >Profitability: Net income surged to $2.46B compared to $596M last year.
- [WARN]** Forensic Flags**: The shift in auto injury reserve releases (favorable development) is the primary driver of earnings. Monitor for any signs of "reserve release exhaustion" in Q2.
Technical Analysis & Trade Timing
- >Momentum: The stock is in a confirmed BULLISH_UPTREND. Trading above all key SMAs (5, 10, 50, 200).
- >RSI: At 66.29, approaching overbought territory. Not quite at the 70+ danger zone, which provides room for a push to new highs.
- >Reconciliation: Fundamentals are strong (earnings beat) and technicals are aligned. Avoid chasing here; wait for a shallow pullback to the 10-day/50-day range to improve the R/R.
Short-Term Trading Strategy (2-5 Days)
- >Timeframe: Swing Trade (2–5 Days).
- >Position Size: 3% of portfolio.
- >Catalyst: Market reaction to recent analyst upgrades (BMO target hike to $250).
- >Stop Loss: $215.00 trailing.
Thesis: Allstate has successfully navigated the inflationary claims environment, with Q1 margins expanding rapidly due to pricing power and improved claims management. The $4B buyback program provides a solid floor for valuation.